Theralase Technologies Inc (TLT_CDNX) analyst actions
Rating and price-target actions on TLT_CDNX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the TLT_CDNX overview →
No TLT_CDNX analyst action events in the measured window.
Nothing matched in the current window — the TLT_CDNX overview has every event we measure for this name.
Get an email when TLT_CDNX moves on news →Keep exploring
More TLT_CDNX: earnings → · SEC filings → · TLT_CDNX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Arch Biopartners Inc (ARCH_CDNX) | 48 | -0.59% | 19% |
| SINO BIOPHARM ORD (SBMFF) | 48 | 0.00% | 4% |
| DEMANT HLDG U/ADR (WILYY) | 48 | 0.00% | 18% |
| HLS THERAPEUTICS INC (HLTRF) | 47 | 0.00% | 24% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.